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Abstract 
Background: Designing a vaccine against Plasmodium vivax has focused on selecting antigens involved in invasion 
mechanisms that must have domains with low polymorphism for avoiding allele‑specific immune responses. The 
rhoptry neck protein 4 (RON4) forms part of the tight junction, which is essential in the invasion of hepatocytes and/
or erythrocytes; however, little is known about this locus’ genetic diversity.
Methods: DNA sequences from 73 Colombian clinical isolates from pvron4 gene were analysed for characterizing 
their genetic diversity; pvron4 haplotype number and distribution, as well as the evolutionary forces determining 
diversity pattern, were assessed by population genetics and molecular evolutionary approaches.
Results: ron4 has low genetic diversity in P. vivax at sequence level; however, a variable amount of tandem repeats at 
the N‑terminal region leads to extensive size polymorphism. This region seems to be exposed to the immune system. 
The central region has a putative esterase/lipase domain which, like the protein’s C‑terminal fragment, is highly con‑
served at intra‑ and inter‑species level. Both regions are under purifying selection.
Conclusions: pvron4 is the locus having the lowest genetic diversity described to date for P. vivax. The repeat regions 
in the N‑terminal region could be associated with immune evasion mechanisms while the central region and the 
C‑terminal region seem to be under functional or structural constraint. Bearing such results in mind, the PvRON4 
central and/or C‑terminal portions represent promising candidates when designing a subunit‑based vaccine as they 
are aimed at avoiding an allele‑specific immune response, which might limit vaccine efficacy.
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Background
Malaria is the parasitic disease having the greatest impact 
on public health [1]. It is caused by different species 
from the Plasmodium genus, these being widely distrib-
uted throughout the world’s tropical and sub-tropical 
regions [2]. These parasites cause 140–300 million clini-
cal cases and more than half a million deaths annually 
[3, 4]. Plasmodium falciparum is considered the most 
lethal species, mainly affecting vulnerable populations in 
sub-Saharan Africa [4]. Even though efforts were initially 
concentrated on controlling this species, reports of ever-
increasingly severe cases caused by Plasmodium vivax 
[5] and the appearance of drug-resistant strains during 
the last few years [6, 7] has made this species a growing 
public health problem, affecting more than a third of the 
world’s population, having high prevalence in Asia and 
South and Central America [3, 7, 8].
Designing an anti-malarial vaccine against P. vivax 
(as for P. falciparum) has been focused on blocking 
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parasite-host interactions during different parasitic 
stages, especially during the blood phase responsible 
for the disease’s clinical manifestations [9, 10]. A large 
amount of P. vivax antigens have been characterized to 
date [10, 11], however, their genetic diversity should 
be assessed for selecting the best antigens for vaccine 
development [10, 12]. Highly polymorphic antigens can 
provoke allele-specific immune responses leading to pro-
tection having low efficacy after vaccination. On the con-
trary, those having limited diversity are attractive targets 
for being evaluated as candidates as they avoid an allele-
specific immune response [13].
Most antigens characterized to date have been mero-
zoite proteins [10, 11], including the microneme AMA1 
protein and rhoptry neck (RONs) proteins. The interac-
tion between these proteins (specifically AMA1–RON2) 
has been well described in Toxoplasma gondii and P. 
falciparum, these being the structural basis for the tight 
junction (TJ), a connective ring through which a parasite 
enters a host cell [14–18].
The RON protein complex (characterized in P. falcipa-
rum) consists of RON2, RON4 and RON5 proteins [14, 
17, 19]. Even though the mechanisms regarding func-
tion and interaction between the complex’s proteins 
are not clear, they are considered important targets for 
blocking invasion. Various studies have highlighted the 
potential of AMA1 and RON2 as vaccine candidates, 
however, current knowledge concerning the other RONs 
is deficient. Co-localization studies and invasion models 
described for Plasmodium spp and T. gondii have led to 
establishing RON4’s convincing participation in the TJ 
[15, 17, 20, 21]. Likewise, its expression in the parasite’s 
invasive forms [21–23], the ability to provoke an immune 
response in natural malarial infections [23] and the pro-
tein’s conserved nature, specifically towards the C-termi-
nal (inferred by comparative analysis between PfRON4 
and TgRON4 amino acid sequences) [24] suggest that 
this protein plays an important role for the parasite and 
could thus be evaluated as vaccine candidate.
The P. falciparum RON4 orthologue has recently 
been characterized in the P. vivax VCG-I strain (Vivax 
Colombia Guaviare-I) [22]. PvRON4 (P. vivax RON4) is 
encoded by a gene having around 2657 bp in this species, 
expressed during the last hours of the intra-erythrocyte 
cycle and secreted from the rhoptry neck. This consists 
of signal peptide sequence, a low complexity domain 
formed by two types of tandem repeats, a double spiral 
alpha helix domain and five conserved cysteines towards 
the C-terminal [22]; the latter region seems to be highly 
conserved among P. vivax and parasite species infecting 
monkeys [25].
Bearing RON4’s potential participation in invasion in 
mind and given that parasite antigen genetic diversity 
is an obstacle for designing a completely effective vac-
cine against P. vivax, this study was thus aimed at using 
Colombian clinical isolates for evaluating pvron4 locus 
genetic diversity and the evolutionary mechanisms deter-
mining its variation pattern.
Methods
Sample collection
Plasmodium vivax genomic DNA was obtained from 73 
clinical isolates collected from 2007 to 2015 (2007: 10, 
2008: 12, 2010: 18, and 2015: 33 samples). These came 
from Colombia’s Pacific coast region (Chocó and Nar-
iño departments), Urabá/lower Cauca/southern Córdoba 
(Córdoba and Antioquia departments) and the Orino-
quia-Amazonia region (Amazonas and Guainía depart-
ments), representing the three regions having the greatest 
transmissibility in Colombia [26]. More than 360,000 
cases of P. vivax infection were recorded between 2007 
and 2015, more than 14 % of them regarding Colombia’s 
Pacific coastal region, Urabá/lower Cauca/southern Cór-
doba 62  % while 7.5  % of P. vivax cases were recorded 
in the Orinoquia-Amazonia region. Malaria sympto-
matic patients (living in the regions described above) 
were diagnosed with P. vivax  infection by microscopy 
and then invited to donate 5 mL of venous blood. Some 
Amazonia samples were collected and diagnosed, as has 
been reported elsewhere [27]. Male and female patients 
aged 16–64 years were invited to participate in the study. 
DNA was extracted and stored at −20  °C before being 
processed and were genotyped by PCR-RFLP from the 
pvmsp-3α gene.
Amplifying, cloning and sequencing the pvron4 locus
A set of primers was designed to amplify and clone 
pvron4 based on Sal-I genomic sequence (GenBank 
accession number AAKM01000005.1), sequences being 
as follows: pvron4 dir 5′ CACAGTGCAACCATGTCTCG 
3′ (20 bp) and pvron4 rev 5′ GCAAGCTAATTTCACAA 
GTCTTC 3′ (23  bp) primers. Touchdown-PCR was 
used for amplification using the KAPA-HiFi HotStart 
Readymix enzyme (Kapa Biosystems) in 25 μL reactions 
using VCG-I strain genomic DNA as positive control. 
Thermal conditions were as follows: a 5 min denaturing 
step at 95 °C, 10 cycles consisting of 20 s at 98 °C, 15 s at 
68 °C (temperature was reduced by one degree per cycle) 
and 1 min at 72 °C, followed by 35 cycles of 20 s at 98 °C, 
15 s at 60 °C, 1 min at 72 °C and a final 5-min extension 
at 72 °C. PCR products were purified using an UltraClean 
PCR Clean-up purification kit (MOBIO).
The amplicons were ligated in pGEM T-easy cloning 
vector and then used for transforming Escherichia coli 
JM109 strain cells. Recombinant bacteria were selected 
by the alpha complementation method and their growth 
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ability in the presence of ampicillin. These were con-
firmed by PCR using MangoTaq DNA polymerase and 
internal primers for the gene (intdir: 5′ TGTGGGTGG 
CGAGAGTG 3′ (17  bp), and intrev: 5′ ATATTTCC 
ATTGCTGTACTAGG 3′ (22  bp), designed on Sal-I 
genomic sequence) using the following thermal condi-
tions a 5 min denaturing step at 95 °C, 35 cycles of 20 s 
at 98 °C, 15 s at 60 °C, 1 min at 72 °C and a final 5-min 
extension at 72  °C. The plasmid from the two recombi-
nant colonies per sample was extracted using an Ultra-
Clean 6 Minute Mini Plasmid Prep kit (MOBIO) and sent 
to be sequenced using a BigDye Terminator kit (MAC-
ROGEN, Seoul, South Korea), with universal prim-
ers SP6 Promoter Primer (Cat.# Q5011), T7 Promoter 
Primer (Cat.# Q5021) [28] and a set of internal prim-
ers (pvron4dseq: 5′ CACTAGAAAAGCTAAACATA 
AACC 3′ (24 bp), and pvron4rseq: 5′ ACTCCAATGGT 
CCTCAAC 3′ (18  bp) designed on the Sal-I genomic 
sequence) for sequencing.
Statistical analysis of pvron4 sequences
The electropherograms obtained by sequenc-
ing were assembled using CLC DNA workbench v.3 
software (CLC bio, Cambridge, MA, USA). The 73 
consensus sequences obtained in this study (Addi-
tional file  1), 7 reference sequences (from the Sal-
vador-I (Sal-I, GenBank: XM_001615228.1), 
Mauritania-I (GenBank: AFNI01000694.1), India-
VII (GenBank: AFBK01001155.1), Brazil-I (Gen-
Bank: AFMK01001544.1/AFMK01001546.1), North 
Korea (GenBank: AFNJ01001110.1), ctg (GenBank: 
AAKM01000005) and P01 (GeneDB: PVP01_0916600.1) 
strains) and 13 orthologous sequences (from Plasmo-
dium cynomolgi (GeneBank: BAEJ01000746.1), Plasmo-
dium knowlesi (GeneBank: NC_011910.1), Plasmodium 
inui (GeneBank: AMYR01000790.1/AMYR01000791.1), 
Plasmodium fragile (GeneBank: NW_012192637.1), 
Plasmodium coatneyi (GeneBank: CM002860.1), Plas-
modium reichenowi (GeneBank: LVLA01000012.1), P. 
falciparum (GeneBank: XM_001347803.2), Plasmodium 
bergei (GeneBank: CAAI01002287.1), Plasmodium yoelii 
(GeneBank: AABL01000590.1), Plasmodium chabaudi 
(GeneBank: CAAJ01004050.1), Plasmodium vinckei 
(GeneBank: AMYS01000107.1), Plasmodium gaboni 
(GeneBank: LVLB01000012.1), and Plasmodium galli-
naceum (Sanger Institute: gal28a.d000001405.Contig1/
gal28a.d000000110.Contig1) were used for obtaining the 
deduced amino acid sequence used for multiple align-
ment with the MUSCLE algorithm [29]. Such alignment 
was manually edited to ensure correct repeat region 
alignment and then used for inferring DNA alignment by 
Pal2Nal software [30]. The T-REKS algorithm was used 
for identifying repeat regions [31].
DnaSP v.5 software [32] was used for calculating 
genetic diversity regarding Colombian sequences and P. 
vivax reference sequences alignment using estimators 
based on single nucleotide polymorphism (SNP) and 
sequence length (InDels). Tajima [33], Fu and Li [34], Fu 
[35], Fay and Wu [36] tests were used for evaluating devi-
ations from the neutral model of molecular evolution, 
bearing coalescence simulations in mind for obtaining 
confidence intervals and their statistical significance. The 
repeat regions or those having gaps were not taken into 
account for analysis.
The Nei-Gojobori modified method [37] with MEGA 
v.6 software [38] was used for calculating the average 
number of synonymous substitutions per synonymous 
site (dS) and the average number of non-synonymous 
substitutions per non-synonymous site (dN) at intra-
species level. The average amount of synonymous diver-
gences per synonymous site (KS) and the average amount 
of non-synonymous divergences per non-synonymous 
site (KN) were calculated by modified Nei-Gojobori 
method with Jukes-Cantor correction [39] for determin-
ing natural selection signals throughout Plasmodium 
spp evolutionary history (using the P. vivax sequences, 
together with phylogenetically close parasites’ ortholo-
gous sequences). The differences between intra- and 
inter-species substitution rates were determined by Fish-
er’s exact test (recommended when the amount of syn-
onymous and/or no-synonymous substitutions is fewer 
than ten) or the Z-test incorporated in MEGA software 
v6. Additionally, the McDonald–Kreitman (MK) test [40] 
with Jukes-Cantor correction was used for evaluating 
neutrality deviations using the Standard & Generalized 
McDonald–Kreitman Test web server [41, 42].
A sliding window was used for analysing evolutionary 
rate (ω  =  dN/dS and/or KN/KS) by evaluating the effect 
of selection throughout the gene. Individual sites under 
selection were identified by calculating synonymous and 
non-synonymous substitution rates per codon using 
SLAC, FEL, REL, IFEL [43], MEME [44], and FUBAR 
methods [45] in the Datamonkey online server [46]. 
Repeat regions or those having gaps were not taken into 
account for this analysis.
The random effects likelihood (REL)-branch-site 
method [47] was used for evaluating the existence of line-
ages under episodic diversifying selection in Plasmodium 
for the ron4 locus. The MUSCLE algorithm was used for 
aligning 14 orthologous protein sequences from different 
species from the genus; this was then used for inferring 
the best evolutionary model using MEGA software. Phy-
logeny was then inferred by using the maximum likeli-
hood method with the JFF + G + F model. This is used as 
reference for analysing lineage-specific positive selection 
with the REL-branch-site method in the HyPhy package 
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[48], using a DNA alignment inferred by Pal2Nal from 
aligning amino acids.
Effective number of codons
ENCprime [49] and DnaSP software were used for esti-
mating the effective number of codons (ENC). This is a 
measurement of selective pressure at translational level, 
leading to protein function loss or gain [49]. This test 
compares the use of each codon versus a null distribution 
(uniform use of synonymous codons). ENC values close 
to 61 indicate that all synonymous codons for each amino 
acid are used equitably, while values close to 0 suggest 
bias or preferential codon use [50]. Statistical signifi-
cance could be affected by gene length or recombination 
[50]. The codon bias index (CBI) was thus used, which 
takes values ranging from 0 (uniform use of synonymous 
codons) to 1 (maximum codon bias) [51].
Linkage disequilibrium and recombination
Linkage disequilibrium (LD) was evaluated by calculat-
ing the ZnS estimator [52]. A linear regression between 
this and the nucleotide distance was performed to see 
whether intragenic recombination occurred in pvron4. 
Recombination was also evaluated by ZZ estimator [53], 
the minimum number of recombination events (Rm) 
[54], the GARD algorithm [55] and the RDP v.3 software 
[56].
pvron4 locus differentiation and population genetic 
structure
The degree of genetic differentiation (or inter-population 
heterogeneity) in the pvron4 locus among Colombian P. 
vivax malaria-endemic regions was estimated by analysis 
of molecular variance (AMOVA) and Wright’s fixating 
index (FST), using the Arlequin v.3.1 software [57]. NET-
WORK v.5 software was used for constructing a median 
joining network for evaluating possible mutational path-
ways giving rise to pvron4 haplotypes, their distribution 
and frequencies. This method expresses multiple plau-
sible evolutionary pathways as cycles, bound by vectors 
interpreted as extinct ancestral sequences [58].
Predicting pvron4 putative domains and antigenic 
potential
The Blastp algorithm from the NCBI web server was used 
for identifying putative domains in PvRON4 using the 
Sal-I sequence as reference. The B-cell epitope prediction 
tool available at the immune epitope database (IEDB) 
server was used for evaluating PvRON4s antigenic poten-
tial regarding its antigenicity [59], its hydrophobicity 
[60], protein solvent availability [61] and its potential 
linear B-cell epitopes [62]. These tests were done with 
two PvRON4 haplotypes differentiated by the amount of 
repeats: haplotype 6 (one copy of GEHGEHAEHGE) and 
haplotype 17 (seven copies of the repeat), to evaluate the 
effect of repeat number on protein antigenic behavior.
Results
pvron4 locus genetic diversity
Seventy-three sequences from the pvron4 locus obtained 
from the P. vivax Colombian population (24 from Orino-
quia-Amazonia, 21 from the Pacific coast and 28 from 
Urabá/lower-Cauca/southern Córdoba) were analysed. 
pvron4 was initially annotated from the VCG-I strain as 
being a 2657  bp gene [22], however, the locus analysed 
from Colombian samples had a variation in length due 
to two tandem repeats located towards the gene’s 5′-end 
(Fig. 1). These repeats consisted of copies of the GTGG 
CGAGA nucleotide sequence encoding GES amino acids 
(repeated one to three times) and a longer sequence 
CGGAGAGCACGGTGAACACGCTGAACATGGGGA 
GCA encoding the GEHGEHAEHGE peptide (repeated 
one to seven times).
Few SNPs were found. Regarding the 2542 sites ana-
lysed concerning the Colombian sequences and the refer-
ence ones, the number of SNPs varied from five to eight 
(Table 1). The genetic diversity estimators gave low val-
ues (θw = 4.7 × 10−4 and π = 4.1 × 10−4) in the P. vivax 
Colombian population. Such values remained constant 
when comparing the Colombian sequences to the refer-
ence ones (Table 1). Likewise, the total amount of pvron4 
haplotypes identified and haplotype diversity were low 
(Table 1), however, 15 haplotypes in the Colombian pop-
ulation (21 when Colombian and reference sequences are 
analysed together) and high diversity estimator values 
(Table 1) were found when analysing insertions/deletions 
(InDels) in pvron4. Bearing the SNPs and InDels between 
the pvron4 reference sequence and Colombian sequences 
in mind, 32 haplotypes were identified (Additional file 2).
Evaluating the effect of selection on the pvron4 locus
No statistically significant values were found for pvron4 
when using the Tajima, Fu and Li, Fay and Wu and Fu 
estimators (Table 2). Likewise, the MK test did not reveal 
any deviations regarding neutrality (Table  3), however, 
the dN − dS difference (Table 3) showed that the synony-
mous substitution rate was higher than the non-synon-
ymous substitution rate (p =  0.000, Fisher’s exact test), 
suggesting that pvron4 was under purifying selection. 
The sliding windows led to ω < 1 values being observed 
throughout the gene (Fig. 1).
When comparing phylogenetically related species, the 
sliding window gave ω < 1 values, with few regions hav-
ing ω ≥ 1 (positions 1172–1325, 2955–2975 and in posi-
tion 2955; Fig. 1). The KN − KS difference (Table 3) gave 
negative values suggesting that purifying selection has 
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played an important role in this locus’ evolutionary his-
tory in the genus Plasmodium. On the other hand, four 
negatively selected sites (28, 112, 149, 643; Fig.  1) were 
found throughout the gene in P. vivax when calculat-
ing selection per codon based on maximum probability 
methods (SCAL, FEL, IFEL, REL, and FUBAR) and the 
Bayesian method (MEME), while no sites were found 
to be under positive selection (Fig.  1). These methods 
revealed 162 sites under negative selection and 21 under 
positive selection between species (Fig. 1).
Phylogeny was inferred from orthologous sequences 
from 14 Plasmodium species. This was used as reference 
framework for the REL-branch-site test. This method 
led to finding six branches (lineages) having evidence of 
episodic selection (Fig. 2). Three were ancestral branches 
(internal) while the other three (external) had given rise 
to Plasmodium inui, Plasmodium chabaudi and Plasmo-
dium gaboni. The MEME method revealed codons under 
diversifying episodic selection.
Effective number of codons
Given the high conservation of the pvron4 locus, devia-
tion regarding the effective use of codons was evaluated 
as a means of selection at translational level. The ENC 
Fig. 1 Representation of pvron4 encoding DNA sequence and sliding window for ω rate. ron4 ω values (dN/dS) within P. vivax are shown in green 
throughout. Likewise, ω divergence rates (KN/KS) between the species infecting primates and P. vivax are shown in blue (for the species evolutionar‑
ily closest to P. vivax) and red (most distant). A representation of the ron4 gene is given below the sliding window indicating signal peptide (blue), 
the repeat region (black) and the putative esterase/lipase domain (purple). The P. vivax SNP positions are shown as discontinue lines, their number‑
ing is based on Additional file 2 alignment. The sites under purifying selection within species are represented by light green lines and dark green 
between species while positively selected sites between species are shown by red lines
Table 1 pvron4 genetic diversity estimators calculated from single nucleotide polymorphism and sequence length poly-
morphism
Genetic diversity estimators were calculated using the reference sequences obtained from databases together with Colombian isolates as well as for just Colombian 
isolates’ sequences
n number of isolates analysed, sites total of sites analysed excluding gaps, Ss number of segregating sites, S number of singleton sites, Ps number of informative-
parsimonious sites, H number of haplotypes, Hd haplotype diversity, θw Watterson estimator, π nucleotide diversity per site
Single nucleotide polymorphism Sequence length polymorphism
n Sites Ss S Ps H Hd θw π Sites No InDels H Hd π
Colombian and reference isolates
80 2542 8 3 5 11 0.67 7.6 × 10−4 4.3 × 10−4 408 21 21 0.82 9.9 × 10−4
Colombian isolates
73 2464 5 0 5 8 0.65 4.7 × 10−4 4.1 × 10−4 289 15 15 0.78 8.0 × 10−4
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for pvron4 estimated by ENCprime (N’c  =  53, scaled 
X2 = 0.103) and DnaSP (ENC = 55.4, scaled X2 = 0.159) 
gave values close to 61, with a CBI value of 0.162, sug-
gesting that there was no bias regarding the effective use 
of codons, thereby ruling out translational selection.
Linkage disequilibrium and recombination
The ZnS estimator was used for evaluating LD between 
pvron4 polymorphisms, giving 0.15. Linear regression 
between the LD and nucleotide distance showed a reduc-
tion in LD as distance increased, thereby suggesting 
recombination. However, the ZZ estimator gave −0.0019 
and no minimum recombination sites were detected. 
Likewise, GARD methods found no breakpoints nor did 
RDP software reveal recombination tracks.
The Plasmodium vivax Colombian population’s genetic 
structure regarding the pvron4 locus
An AMOVA between the three Colombian regions was 
calculated for evaluating pvron4 geospatial genetic diver-
sity in Colombia, as well as Wright’s fixation index (FST) 
between the different populations (regions). AMOVA 
revealed statistically significant differences between 
the sub-populations within the regions (FSC  =  0.06, 
p =  0.04). The Nariño sub-population (from the Pacific 
region) could be responsible for genetic differences 
regarding each of the other subpopulations (Additional 
files 3, 4). Calculating the FST index between populations 
(regions) gave values close to 0. There was a statistically 
significant difference between the Urabá/lower Cauca/
southern Córdoba and Orinoquia-Amazonia regions 
(Table 4).
A median joining network was used for better 
understanding the evolutionary relationship between 
pvron4 haplotypes for describing the set of potential 
mutational pathways giving rise to the 32 haplotypes 
available for the locus (Fig.  3 and Additional file  3). 
The network showed that the parasite’s populations 
shared haplotypes, regardless of geographical region, 
which were related by different mutational pathways 
and ancestral sequences (median vectors) (Fig.  3 and 
Additional file 3). The most frequently occurring hap-
lotypes were H5 (53.1  %), followed by H4 (31.2  %), 
H13 (25  %), H3 and H20 (12.5  % each). The presence 
of unique haplotypes in the Nariño (H7, H8 and H10) 
and Amazonas populations (H21, H22, H2) should 
be noted as they could be considered rare or specific 
regional alleles.
Table 2 Neutrality, linkage disequilibrium and recombination tests for the pvron4 gene in the Plasmodium vivax Colom-
bian population
No statistically significant values were found in neutrality tests
ZnS average of R^2 for all comparison pairs, ZZ: ZnS − Za difference, Rm minimum amount of recombination events, NP not performed, since not all sequences 
belonged to the same population
τ  p < 0.05
N Gene Tajima Fu and Li Fay and Wu’s H Fu´s Fs ZnS ZZ RM
D D* F*
Colombian and reference isolates
80 2578 NP NP NP NP NP 0.154τ −0.002 0
Colombian isolates
73 2578 −0.037 −0.035 −0.020 −0.039 −0.028 0.163τ −0.002 0
Table 3 Difference between dN − dS, KN − KS and the neutral index from MK test
Non-synonymous substitution rate (dN) and synonymous substitution rate (dS) within P. vivax. Non-synonymous (KN) and synonymous (KS) divergence between P. vivax 
and phylogenetically close species. Neutrality index (NI) estimated by McDonald–Kreitman test using Jukes Cantor correction
P.cyn P. cynomolgi, P.inu P. inui, P.kno P. knowlesi, P.coa P. coatneyi, P.fra P. fragile
* p < 0.01
β  p < 0.001
P. vivax P. vivax/Plasmodium ssp
P. knowlesi P. inui P. coatneyi P. cynomolgi P. fragile P.cyn/P.inu P.kno/P.coa/P.fra
dN − dS KN − KS
−0.002* −0.011β −0.006β −0.006β −0.009β −0.010β −0.015β −0.025β
NI
0.696 0.597 0.857 1.133 0.919
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Predicting pvron4 putative domains and antigenic 
potential
Analysing the PvRON4 sequence from the Sal-I strain 
revealed the presence of a putative domain for the ester-
ase/lipase (pfam05057) protein superfamily between 
amino acids 311–425 (nucleotides 931 to 1275, num-
bers based on the Sal-I reference sequence, GenBank 
access number: XM_001615228.1) e-value 1.10e-03. 
This domain was located after the repeat region and was 
highly conserved (Fig. 1).
According to antigenicity and B-cell linear epitope pre-
diction, there was a potentially antigenic region between 
positions 41–171 and 178 up to 256 for haplotype 6 and 
up to position 340 for haplotype 17 (Additional file  5). 
This agreed with hydrophobicity and solvent accessibility 
predictions so that the PvRON4 N-terminal region seems 
to be a potential immune target. By contrast, the central 
region (following the repeat region) and the C-terminal 
seemed to be less antigenic, being less solvent-exposed 
(Additional file 5).
Discussion
Various proteins contained within the parasite’s apical 
organelles seem to be crucial for host cell invasion and 
thus represent promising vaccine targets. RON complex 
proteins are among the proteins localized in the apical 
organelles, forming part of the TJ [17, 21, 63, 64]. This 
TJ plays a decisive role in parasite entry to a host cell and 
closure of the parasitophorous vacuole [17]. The RON4 
Fig. 2 Lineages subject to episodic diversifying selection in ron4. The branches (lineages) under episodic positive selection were identified by the 
Branch‑site REL method. The figure shows the ω+ values, the percentage of sites (Pr [ω = ω+]) and p values. The shade of each colour on branches 
indicates strength of selection (red shows ω+ > 15, blue ω− ≤ 1 and grey ω = 1). The size of each colour represents the percentage of sites in the 
corresponding class. Branches have been classified as undergoing episodic diversifying selection by the p value corrected for multiple testing using 
the Holm‑Bonferroni method at p < 0.05
Table 4 Inter-population FST statistic for pvron4
FST was calculated for parasite populations in three Colombian regions. Values 
close to 0 indicate low genetic differentiation while values close to 1 indicate 
high genetic differentiation. Values below the diagonal indicate the FST value 
and those above the diagonal represent the p values. Values in italics indicate 
significant differences having p < 0.02
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protein located in the invasion complex is present in 
Phylum Apicomplexa members [15, 23, 24], suggesting 
that it forms part of a conserved invasion pathway. This 
protein has thus been described as a potential vaccine 
candidate.
A vaccine candidate must have several characteristics 
[10, 65]; one of them is to have low genetic diversity to 
avoid allele-specific immune responses, which could 
reduce vaccine efficacy. The analysis of P. falciparum 
laboratory strains from different geographically origins 
showed the pfron4 locus as being a highly conserved 
locus, having just one amino acid substitution [23]. Plas-
modium vivax ron4 seems to have the same pattern, as 
analysing five reference sequences revealed low genetic 
diversity [25]. This study thus analysed 73 clinical isolates 
from the Colombian population for confirming pvron4 as 
a highly conserved gene in P. vivax. In spite of increas-
ing the number of sequences analysed, pvron4 diversity 
remained low, the present study’s results showing that 
pvron4 had lower genetic diversity than in a previous 
report [25]. Only eight SNPs were identified in the 80 
available sequences compared to 14 previously identi-
fied ones [25]. Such high number of previously reported 
SNPs (i.e., 14) was due to erroneous repeat region align-
ment. pvron4 had a similar pattern to that of other apical 
organelle proteins [66, 67]. pvrap1 and pvrap2 had 0.0009 
to 0.001 π [67] while pvron4 had a much lower value than 
pvrap1, suggesting it had low genetic diversity, the locus 
being more conserved to date for P. vivax. As it has been 
suggested for pvrap1 and pvrap2 [67] the low diversity in 
pvron4 could be the consequence of functional/structural 
constraint (see below) due to the key role of this protein 
in parasite invasion.
Even though pvron4 was a highly conserved sequence 
regarding SNP occurrence, it had high polymorphism 
regarding size. Previous studies have identified two types 
of repeats towards the N-terminal of the encoded pro-
tein [22]. These repeats were reported as being imperfect 
copies of amino acids GGEH/SGEH/S and G/AEH. How-
ever, the analysis here performed showed that the pvron4 
repeat region consisted of two types of repeats having 
100 % identity; the first encoded three GES amino acids 
(one to three copies) and the second one GEHGEHAE-
HGE amino acids (one to seven copies). These repeats 
gave a high number of different haplotypes (alleles) in P. 
vivax.
Previous studies have suggested that tandem repeats 
could play an important role as host immune response 
evasion mechanism [68–71]. In this study, 21 haplo-
types were identified in PvRON4 when the InDels were 
Fig. 3 Median‑joining network for Colombian regions. The Figure shows the pvron4 haplotypes identified from the isolates from the three regions 
of Colombia. Haplotypes 22 and 28 were included within haplotype 15 using the contraction star algorithm [86] for simplifying interpretation of the 
network. Each node is a haplotype and its size indicates its frequency. The lines connecting the haplotypes represent the different mutational paths 
and the median vectors are the ancestral sequences explaining the relationship and evolutionary origin
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analysed. PvRON4  N-terminal region seems to be the 
most exposed protein according to solvent availability 
and hydrophobicity results. This region (between signal 
peptide and repeat region) seems to be a potential anti-
genic target due to this being where the largest amount 
of potential B-cell linear epitopes was predicted. The 
repeat sequences identified broadened the solvent-
exposed region and the protein’s antigenic potential. The 
PvRON4  N-terminal region could thus be the region 
exposed to a host’s immune system and repeats could 
be acting as an immunological smokescreen. Further 
antigenic and immunogenic studies are needed to con-
firm such hypothesis. As the repeat region was highly 
conserved regarding sequence, it could play an impor-
tant structural or functional role, as has been suggested 
recently for the CSP [72, 73].
While the N-terminal region might to be exposed to 
the immune system, the central and C-terminal regions 
seem to be under functional constraint. Neutrality tests 
(e.g., Tajima, Fu and Li) gave no statistically significant 
values and neutrality was thus not  ruled out. If pvron4 
is under neutrality then it should show high polymor-
phism unless there is a functional or structural con-
straint [74]. Given that this locus was highly conserved 
regarding sequence, functional/structural constraint is 
probable. However, selection at translational level could 
also be responsible for high conservation in the pvron4 
sequence. Analysing regarding preferential codon use did 
not reveal bias regarding codon use (ENC = 53–55). In 
fact this value was similar to that reported for the com-
plete genome (ENC =  52.18) [75], suggesting that high 
pvron4 locus conservation was not due to selection at 
translational level and could have been a result of strong 
purifying selection.
The dS rate was significantly greater than the dN rate 
according to Fisher’s exact test, suggesting that this locus 
has evolved under purifying selection. However, it is 
not easy to evaluate how natural selection acts in highly 
conserved antigens [66, 76, 77]. Previous studies have 
compared P. vivax sequences to phylogenetically related 
species to evaluate the effect of selection on parasite anti-
gens [66, 76–78]. Sliding window analysis of ω rate gave 
values less than 1 towards the protein’s central region as 
well as towards the C-terminal. The KS was statistically 
greater than KN and various sites under purifying selec-
tion between species were detected in these regions, sug-
gesting that purifying selection plays an important role 
during the locus’ evolution in the genus. Bearing in mind 
that functional regions tend to have slower evolution 
and are usually conserved between species [79], these 
results suggest that the PvRON4 C-terminal and central 
regions could be functionally important. The presence of 
conserved cysteines in the C-terminal portion (usually 
associated with protein–protein interaction) could be 
mediating the interaction between RON4 and AMA-1 
and/or other RONs [16, 80], while the presence of a puta-
tive esterase/lipase domain in the protein’s central region 
could be involved in RON4 entry to the host cell.
Plasmodium falciparum and T. gondii studies have 
shown that the RON4 C-terminal region seems to play 
an important role in invasion [16, 24]. RON4 is located 
inside red blood cells (RBC), anchoring the AMA1/
RON2 complex [17, 18, 24]; RON4 must thus be secreted 
and enter RBC during initial invasion stages by a yet-
unknown mechanism. The presence of an esterase/lipase 
domain in the PvRON4 central region could provide a 
clue regarding the action mechanism. This is one of the 
protein’s most structured regions, being highly conserved 
among species and containing several sites under puri-
fying selection, suggesting a functional/structural role. 
Therefore, while the PvRON4  N-terminal region seems 
to be associated with evasion of the immune response, 
the central region (containing the esterase/lipase domain) 
could be associated with the rupture of ester bonds in the 
phospholipids constituting host cell membrane. Such 
rupture would enable RON4 entry to RBC or hepatocyte 
cytoplasm. Once inside, the RON4 C-terminal region 
anchors RON proteins, which, in turn, enable AMA1-
mediated interaction between the parasite and host cells. 
It can thus be hypothesized that such putative esterase/
lipase domain could play a role regarding RON4 entry to 
a host cell, however, further functional assays are needed 
to confirm this.
In spite of ron4 being highly conserved between spe-
cies and that purifying selection seems to be important 
during this locus’ evolution in Plasmodium, some sites 
under positive selection were identified, coinciding with 
the regions where ω  >  1 was observed. Previous stud-
ies have shown that some antigens (regardless of their 
genetic diversity) have regions/codons under episodic 
positive selection, which could have enabled adaptation 
to different hosts [76, 81, 82]. The topology obtained for 
ron4 was similar to that obtained when analysing mito-
chondrial DNA [83]. The phylogenetic relationships of 
species infecting rodents and hominids can be seen in 
ron4 phylogeny, however, such relationships have not 
been seen for species infecting monkeys. These species 
have a complex evolutionary history, which includes bio-
geographic aspects, adaptation to new macaque hosts 
and even a change from monkeys to humans [81, 84]. The 
episodic selection observed here might thus have been a 
consequence of this group of parasites’ rapid diversifica-
tion (in the N-terminal region and a small portion of the 
C-terminal region) thereby enabling RON4 to adapt from 
an ancestral population to new available hosts, as previ-
ously suggested [76, 81, 82, 84].
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A relatively high number of haplotypes has been found 
in the pvron4 locus in Colombia, resulting from a com-
bination of SNPs and tandem repeats. AMOVA analy-
sis and median joining showed that Colombian regions 
shared most haplotypes and seemed to be genetically 
similar. However, it was observed that a 6 % of estimated 
variation between these regions was due to differences 
between the subpopulations constituting them. The FST 
value showed that some subpopulations might not be 
genetically similar; this could be associated with the pres-
ence of unique haplotypes. This agreed with studies in 
Colombia involving other parasite antigens [77], as well 
as mitochondrial DNA studies in America [85], suggest-
ing that the parasite population in America is structured 
and has limited gene flow. However, since some subpopu-
lations analysed here had limited sample size, the num-
ber of sequences must be increased for such results to be 
confirmed.
Conclusions
Designing a vaccine which is completely effective against 
the parasites causing malaria requires antigens having 
limited genetic diversity to avoid allele-specific immune 
responses. The pvron4 locus was seen to have low genetic 
diversity regarding SNPs but had a large amount of hap-
lotypes due to tandem repeats located in the proteins’ 
N-terminal, which could be involved in evading the 
immune response. On the other hand, the central and 
C-terminal regions are highly conserved, even between 
species. Such regions are under purifying selection, sug-
gesting that they are under functionally or structurally 
constraint. The central region has a putative esterase/
lipase domain, leading to the hypothesis that this domain 
enables RON4 entry to host cells while the C-terminal 
region anchors the AMA1/RON complex. Bearing the 
aforementioned results in mind, PvRON4 central/C-ter-
minal region would seem to be a promising candidate for 
inclusion when designing a subunit-based vaccine against 
P. vivax.
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